Last reviewed · How we verify
Oralgen
At a glance
| Generic name | Oralgen |
|---|---|
| Also known as | Grass pollen extract, grass pollen extract, grasspollen extract |
| Sponsor | Artu Biologicals |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of Grass Pollen Sublingual Immunotherapy (PHASE2, PHASE3)
- Long-term Efficacy and Safety Study With Oralgen Grass Pollen (PHASE2, PHASE3)
- A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis (PHASE3)
- Effects of Sublingual Immunotherapy on Grasspollen Allergy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Oralgen CI brief — competitive landscape report
- Oralgen updates RSS · CI watch RSS
- Artu Biologicals portfolio CI